Vanberra Signal

Celavet

Curated by Signal

Develops stem cell therapy for equine animals

Overview

Celavet is a regenerative medicine company developing stem cell-based therapies for the treatment and prevention of orthopedic injuries and diseases in large and small animals. Its proprietary technology is based on the premise that embryonic stem cells are pluripotent and have the capacity to renew damaged tissues. The company is developing stem cells to be non-immunogenic and it claims that its initial studies have not shown rejection of these cells by the transplanted animal. The stem cells for therapy are extracted, processed, and then grown in a specialized media and stored. When required for transplantation, the cells are thawed, reintroduced into the growth media, and shipped to the treating veterinarian on the same day.

Key facts

Founded
2008

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • AI-driven theoretical and experimental systems biology to understand disease and develop therapeutics

    Life Sciences TechnologyLos Angeles, United States
  • Provider of bioinformatics platform for epigenomic profiling

    Life Sciences TechnologyNewark, United States
  • Provider of devices for remote patient monitoring

    Life Sciences TechnologyIrvine, United States

About Celavet

What does Celavet do?

Celavet is a regenerative medicine company developing stem cell-based therapies for the treatment and prevention of orthopedic injuries and diseases in large and small animals.

Where is Celavet headquartered?

Celavet is headquartered in Reading, United States.

When was Celavet founded?

Celavet was founded in 2008.

Which sector is Celavet in?

Celavet operates in Life Sciences Technology.

Who are Celavet's competitors?

Companies similar to Celavet include Lyceum, Genome Profiling, and Lotus Health.